ITEMS IN AFP WITH KEYWORD:
Mar 15, 2021 Issue
Screening for High Blood Pressure in Children and Adolescents [Putting Prevention into Practice]
A 10-year-old boy with obesity and a family history significant for hypertension and hyperlipidemia presents to your clinic for a well-child examination. The parents are concerned about their child 's risk for hypertension and ask whether they should be monitoring his blood pressure.
Feb 15, 2021 Issue
Screening for High Blood Pressure in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for high blood pressure in children and adolescents.
Most adults with primary hypertension will eventually require treatment with at least two antihypertensive agents. This article focuses on combination therapy—when to initiate it, choice of agents, and special populations whose comorbid conditions influence those choices.
The intensification of antihypertensive regimens on discharge in older adults hospitalized for noncardiac conditions is associated with an increased risk of readmission (number needed to harm [NNH] = 27) and medication-related serious adverse events (NNH = 63) within 30 days.
The American College of Obstetricians and Gynecologists (ACOG) has released an updated practice bulletin to outline diagnosis, effects on pregnancy outcomes, and approaches for management based on new evidence.
Nov 15, 2019 Issue
Gestational Hypertension and Preeclampsia: A Practice Bulletin from ACOG [Practice Guidelines]
Globally, hypertensive disorders of pregnancy are one of the main causes of maternal death. The American College of Obstetricians and Gynecologists has released a practice bulletin to outline diagnosis and treatment recommendations for these conditions.
RAS inhibitors, which include angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and renin inhibitors, should not be used as first-line agents.
Oct 1, 2019 Issue
Antihypertensive Drug Therapy for Mild to Moderate Hypertension During Pregnancy [Cochrane for Clinicians]
Compared with placebo, antihypertensive drug therapy for mild to moderate hypertension (defined by the authors as a blood pressure of 140 to 169 mm Hg systolic or 90 to 109 mm Hg diastolic) caused by chronic hypertension, gestational hypertension, or preeclampsia during pregnancy does not affect any pregnancy outcomes.
Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.
Mar 15, 2019 Issue
Coaching Patients About Successful Blood Pressure Management [Lown Right Care: Reducing Overuse and Underuse]
A collaboration between AFP and the Lown Institute promotes a vision of delivering heath care that is based on the evidence, balanced in its approach, and focused on the patient.